Correlation between serum CA724 and gastric cancer: Multiple analyses based on Chinese population

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 9031-9039

  Chen, Xin Zu ^a   Zhang, Wei Ke ^a   Yang, Kun ^a   Wang, Lan Lan ^a   Liu, Jin ^a   Wang, Li ^a   Hu, Jian Kun ^a   Zhang, Bo ^a   Chen, Zhi Xin ^a   Chen, Jia Ping ^a   Zhou, Zong Guang ^a   Mo, Xian Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CA199; CA724; CEA; Chinese; Gastric cancer; Meta analysis; Summary ROC; Tumor biomarker

Indexed keywords

CA 125 ANTIGEN; CA 153 ANTIGEN; CA 199 ANTIGEN; CA 242 ANTIGEN; CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 724; CARCINOEMBRYONIC ANTIGEN; UNCLASSIFIED DRUG;

ACCURACY; ANTIGEN BLOOD LEVEL; ARTICLE; BENIGN TUMOR; BLOOD LEVEL; CANCER PATIENT; CHINESE; CONTROLLED STUDY; DISEASE MARKER; HEALTH CARE PERSONNEL; HUMAN; HUMAN TISSUE; META ANALYSIS; POST HOC ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; STOMACH DISEASE; SYSTEMATIC REVIEW; TUMOR BIOPSY;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; HUMANS; ROC CURVE; STOMACH NEOPLASMS;

EID: 84865151354     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1774-x     Document Type: Article

References (56)

1. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137-2150 (Pubitemid 46655601)
2. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354-362 (Pubitemid 43329250)
3. National Comprehensive Cancer Network (2010) Clinical practice guidelines in oncology: gastric cancer. http://www.nccn.org/professionals/physician-gls/ PDF/gastric.pdf. Accessed 14 August 2010
4. Jeung HC, Rha SY, Noh SH et al (2001) Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. Cancer 91(11):2016-2025 (Pubitemid 32476365)
5. Yang L, Parkin DM, Ferlay J et al (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14(1):243-250 (Pubitemid 40165308)
6. Chen XZ, Jiang K, Hu JK et al (2008) Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol 14(17):2715-2722
7. Duraker N, Celik AN (2001) The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 76(4):266-271 (Pubitemid 32381683)
8. Louhimo J, Kokkola A, Alfthan H et al (2004) Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer. Int J Cancer 111(6):929-933 (Pubitemid 39096242)
9. Gaspar MJ, Arribas I, Coca MC et al (2001) Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 22(5):318-322 (Pubitemid 32823950)
10. Higgins JPT, Green S (eds) (2008) Cochrane handbook for systematic reviews of interventions version 5.0.0. The Cochrane Collaboration. http://www.cochrane.org/resources/handbook.Accessed February 2008
11. Littenberg B, Moses LE (1993) Estimating diagnostic accuracy from multiple conflicting reports: a new analytic method. Med Decis Making 13(4):313-321 (Pubitemid 24013154)
12. Huang LS, Lao M, Shen J et al (2005) The value of combined detection of GPDA, CA72-4 and CA50 in diagnosis of gastric cancer. Cancer Res Prev Treat 32(9):560-561 (in Chinese)
13. Ji XP, Zheng YS, Gao SS (2003) Diagnostic value of combined detection of CA72-4 and CEA for gastric cancer. J Radioimmunol 16(6):354-355 (in Chinese)
14. Jiang LL, Yang ZH (2006) Clinical evaluation of serum tumor markers for gastric cancer. Sichuan J Cancer Control 19(3):200-201 (in Chinese)
15. Li SH, Wang ZZ, Cai JC et al (2006) Clinical significance of combined assay of adrenomedullin, CEA and CA72-4 for diagnosis of gastric cancer. Label Immunoass Clin Med 13(3):175-183 (in Chinese)
16. Liao QL, Wu KW (2006) Detection of serum CA72-4, CA19-9, CA50 and their clinical value before or after surgery of gastric cancer. China J Mod Med 16(14):2180-2183 (in Chinese)
17. Liu Y, Li JG (2007) Clinical value of multi-tumor markers detection with (CEA, CA19-9, CA72-4) for diagnosis of gastric malignancy. J Radioimmunol 20(1):16-18 (in Chinese)
18. Luo WJ, Wu WT, Zeng XQ (2006) The diagnostic value of combined determination of serumCA199 and CA72-4 in the patients with gastric cancer. West China Med J 21(3):519 (in Chinese)
19. Lv XX, Liu B, Zhang RL (2007) Clinical value of combined detection of serum CEA, CA199 and CA724 in patient with gastric cancer. Chin J Clin Oncol Rehabil 14(1):26-28 (in Chinese)
20. Niu XW, Sheng WZ, Qin XY (1999) Analysis of CEA, CA19-9, CA72-4 and helicobacter pylori antibodies in patients with gastric cancer. Chin J Bases Clin Gen Surg 6(3):162-165 (in Chinese)
21. Ren SQ, Niu FH, Cui JJ et al (2006) Combination assay of CA72-4, CA19-9 and CEA in diagnosis of gastric cancer. Henan J Surg 12(6):11 (in Chinese)
22. Song WH, Liu Y, Jiao XC (2006) Diagnosis value of serum PG-I, CA72-4 and MG7Ag in gastric carcinoma. Chin J Postgrad Med 29(7):34-36 (in Chinese)
23. Sun XJ, Zhang Q (2006) The expression of serum CEA and CA72-4 combination assay in patients with gastric cancer. Med Lab Sci Clin 17(5):81 (in Chinese)
24. Wang XP, Zhang TZ (2001) Diagnostic value of combined detection of CA72-4, CA50 and CA19-9 for gastric cancer. Pract J Cancer 16(6):651-652 (in Chinese)
25. Wang Y (2006) Correlation between levels of serum CA724, CA242 and CEA and stages of gastric cancer. J Radioimmunol 19(3):225-226 (in Chinese)
26. Wang YL, Yao XH, Lou GC (2006) Clinical evaluation of five tumor markers in peripheral blood from patients with gastric cancer. J Hangzhou Med Coll 26(4):242-4247 (in Chinese)
27. Xu YC, Chen QA, Sun M (2007) Diagnostic value of combined assay of serum CEA, CA199, CA724 and EMA for gastric cancer. J Radioimmunol 20(3):285-286 (in Chinese)
28. Yang L, Huang B, Lu AG et al (2007) Clinical evaluation of tumor markers MG-7, CEA, CA19-9 and CA72-4 in the diagnosis and the prognostic judgment of gastric carcinoma. J Diagn Concepts Pract 6(1):43-45 (in Chinese)
29. Zeng XP, Zhan XW, Liu DJ et al (2006) Diagnostic value of levels of CA19-9, CA72-4 and CEA in gastric cancer. Pract Clin Med 7(10):8-11 (in Chinese)
30. Zhao JW, Chen M, Hu Y et al (2006) Diagnostic value of combined detection of four tumor markers for gastric cancer. Label Immunoass Clin Med 13(4):196-197 (in Chinese)
31. Chen YG, Ye J (2001) Evaluation of SIMA, CEA, CA50 and CA19-9 in 56 cases of advanced gastric carcinoma. J Taizhou Polytech Inst 1(4):22,34-5. (in Chinese)
32. Miao L, Zhang WX, Liu Z et al (2002) Diagnostic value of combined determination of serum CA19-9 and CA125 and CEA in gastric carcinoma. Mod J Integr Tradit Chin West Med 11(23):2315-2316 (in Chinese)
33. Gu Y, Duan W, Wu XH et al (2006) Combined detection of AFP, CEA, CA19-9 and CA125 in diagnosing malignant tumors of digestive system. J Fourth Mil Med Univ 27(6):518-520 (in Chinese)
34. Shao JG, Ni RZ (1999) Diagnostic value of serum CA19-9 detection for malignant tumors of digestive system. Acta Acad Med Nantong 19(2):170-171 (in Chinese)
35. Chen WZ, Dong L (2007) Diagnostic value of combined tumor markers detection for gastric and colorectal cancers. J Radioimmunol 20(3):220-221 (in Chinese)
36. Liang Z, Wang HF, Wu AZ et al (2005) Clinical value of 12 tumor markers protein biochip in detection of digestive system neoplasm. China Trop Med 5(3):407-409 (in Chinese)
37. Lu ZY, Huang HD, Li YM (2001) Clinical value of serum CEA, CAl9-9 and CA125 measurement in gastric cancer. Hebei Med 7(6):483-486 (in Chinese)
38. Sun X, Chen ZD, Gong H (2004) Detection of 12 tumor markers in 617 cases of malignant tumor. Acta Univ Med Anhui 39(5):396-398 (in Chinese)
39. Sun YP, Shen H (2004) Evaluation of protein-chip system for tumor markers in diagnosis and disease progress of gastric cancer. Chin J Cancer Prev Treat 11(7):703-5 (in Chinese)
40. Wang HZ, Zhao YT, Zhao GQ et al (2004) Combined assay of serum CA19-9 and CA242 in gastric cancer. Chin Gen Surg 13(9):711-712 (in Chinese)
41. Wang J, Zhu YQ, Yang SX et al (2000) Clinical evaluation of combined serum tumor markers (CA242 and CEA) in the diagnosis of gastrointestinal malignant tumor. J Capital Univ Med Sci 21(4):292-294 (in Chinese)
42. Wang Y, Wang XP, Li YR (2005) Value of tumor marker detection in gastric cancer. Sichuan Med 26(9):1020-1021 (in Chinese)
43. Yu JY (2006) The clinical value of multi-tumor markers protein chip assistance diagnostic system in the diagnosis of gastric cancer. J Chin Physician 8(3):317-319 (in Chinese)
44. Zuo Q, Li AM, Miao JX et al (2004) Diagnostic value of multi-tumor markers protein biochip detective system for digestive tract cancer. Chin J Clin Oncol 31(6):337-339 (in Chinese)
45. Chen XZ, Hu JK, Zhou ZG et al (2010) Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer. J Am Coll Surg 210(1):100-105
46. Chen XZ, Hu JK, Yang K et al (2009) Short-term evaluation of laparoscopy-assisted distal gastrectomy for predictive early gastric cancer: a meta-analysis of randomized controlled trials. Surg Laparosc Endosc Percutan Tech 19(4):277-284
47. Seregni E, Ferrari L, Martinetti A et al (2001) Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol 20(2):147-166 (Pubitemid 32520660)
48. Chen XZ, Yang K, Zhang B et al (2011) Is retrieval of >25 lymph nodes a superior criterion for locally advanced gastric cancer surgery? Ann Surg 254(5):834-835
49. Chen XZ, Yang K, Liu J et al (2011) Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World J Gastroenterol 17(40):4542-4544
50. Guadagni F, Roselli M, Amato T et al (1992) CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res 52(5):1222-1227
51. Carpelan-Holmström M, Louhimo J, Stenman UH et al (2002) CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22(4):2311-2316 (Pubitemid 34857058)
52. Reiter W, Stieber P, Reuter C et al (1997) Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Anticancer Res 17(4B):2903-2906 (Pubitemid 27434816)
53. Tocchi A, Costa G, Lepre L et al (1998) The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol 124(8):450-455 (Pubitemid 28407579)
54. Lai IR, Lee WJ, Huang MT et al (2002) Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 49(46):1157-1160
55. Marrelli D, Roviello F, De Stefano A et al (1999) Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 57(1):55-62 (Pubitemid 29308672)
56. Jackson C, Cunningham D, Oliveira J et al (2009) Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):34-36